|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombi-nant tissue plasminogen activator:A secondary analysis of the European-Australa-sian Acute Stroke Study (ECASS II)显示文摘 | Larrue V von Kummer RR Muller A Bluhmki E | | 0，，： | 1 |
| 2 | Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS,NINDS,and EPITHET trials显示文摘 | Lees KR Bluhmki E von Kummer R | 2010 | Lancet2010，375，： | 1 |
| 3 | Time to treatment with intra enous aheplase and outcome in stroke: an updated pooled analysis of E- CASS,AqI,ANTIS, NINDS, and EPITHE3' trials显示文摘 | Lees K R Bluhmki E Vonkummer R | 2010 | Lancet2010，375，9727： | 1 |
| 4 | Time to aheplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS, NINDS, and EPITHET trials 显示文摘 | Lees K R Bluhmki E yon treatment with intravenous Kummer R | 2010 | Lancet2010，375，9727： | 1 |
| 5 | Dichotomized efficacy end points and global end-point analysis applied to the ECASS intentionto-treat data set:post hoc analysis of ECASS 1显示文摘 | Bluhmki E Steiner T | 1998 | Stroke1998，29，： | 1 |
| 6 | Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, Atlantis, NINDS, and EPITHET trials 显示文摘 | Lees KR Bluhmki E von Kummer R | 2010 | Lancet2010，375，： | 1 |
| 7 | Meloxicam in osteo arthritis: a 6-month, double blind comparison with diclofenea sodium显示文摘 | Hosie J Distel M Bluhmki I | 1996 | British Journal of Rheumatology1996，35，： | 1 |
| 8 | A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip显示文摘 | Distel M Bluhmki E | 1996 | Br J Rheumatol1996，351，： | 1 |
| 9 | Time to treatment withintravenous alteplase and outcome in stroke : an updated pooled analy-sis of ECASS, ATLANTIS, NINDS,and EPITHET trials 显示文摘 | Lees K R Bluhmki E von-Kummer R | 2010 | Lan-cet2010，375，9727： | 1 |
| 10 | Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled anal?ysis of ECASS, ATLANTIS, NINDS , and EPITHET trials 显示文摘 | Lees KR Bluhmki E von Kummer R | 2010 | Lan?cet2010，375，9727： | 1 |
| 11 | Time to treatmeat with in travenous alteplase and outcome in stroke:an updated pooled a nalysis of ECASS, ATLANTIS, NINDS, and EPITHET trials 显示文摘 | Lee KR Bluhmki E Von KM | 2010 | Lancet2010，375，： | 1 |
| 12 | Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS,NINDS,and EPITHET trials显示文摘 | Lees KR Bluhmki E von Kummer R | | 0，，： | 1 |
| 13 | Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials 显示文摘 | LEES K R BLUHMKI E Von KUMMER R | 2010 | Lancet2010，375，9727： | 1 |
| 14 | Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of Ecass, Atlantis, NINDS, and Epithet trials 显示文摘 | Lees K R Bluhmki E von Kummer R | 2010 | Lancet2010，375，9727： | 1 |
| 15 | Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials显示文摘 | Lees KR Bluhmki E von Kummer R | 2010 | Lancet2010，375，： | 1 |
| 16 | Time to treat- ment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials显示文摘 | Lees KR Bluhmki E von Kummer R | 2010 | Lancet2010，375，9727： | 1 |
| 17 | Safety of meloxicam:a global analysis of clinical trials显示文摘 | Distel M Mueller C Bluhmki E | 1996 | Br J Rheumatol1996，35，1： | 1 |
| 18 | Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS ,ATLANTIS ,N1NDS ,and EPITHET trials 显示文摘 | Lees KR Bluhmki E von Kummer R | 2010 | Laneet2010，375，9727： | 1 |
| 19 | Safety of meloxieam;a global analysis of clinical trials显示文摘 | Distel M Mueller C Bluhmki E | | 0，，1： | 1 |
| 20 | Time to treatment with intravenous alteplase and outcome in stroke:an updated pooled analysis of ECASS,ATLANTIS,NINDS,and EPITHET trials显示文摘 | Lees KR Bluhmki E von Kummer R | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员